Aarti Pharmalabs Ltd
Thu 13/03/2025,15:59:55 | NSE : AARTIPHARM
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 734.35
Previous Close
₹ 731.20
Volume
268984
Mkt Cap ( Rs. Cr)
₹6696.81
High
₹ 748.50
Low
₹ 726.60
52 Week High
₹ 837.25
52 Week Low
₹ 399.55
Book Value Per Share
₹ 204.88
Dividend Yield
0.00
Face Value
₹ 5.00
What’s Your Call?
Collective community sentiment on Aarti Pharmalabs Ltd
Your Vote -
Buy
85.71%
Hold
0.00%
Sell
14.29%
85.71%
7 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
738.95
499
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
499
Option Chain
Analyzes market sentiment, predicts Aarti Pharmalabs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Aarti Pharmalabs - Alteration Of Capital and Fund Raising-XBRL
-
Aarti Pharmalabs - ESOP/ESOS/ESPS
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aarti Pharmalabs - Copy of Newspaper Publication
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aarti Pharmalabs has declared 50% Interim dividend for the financial year March 2025
-
Aarti Pharmalabs - Record Date For Interim Dividend
-
Aarti Pharmalabs - Corporate Action-Board to consider Dividend
-
Aarti Pharmalabs - Record Date
-
Aarti Pharmalabs - Outcome of Board Meeting-XBRL
-
Aarti Pharmalabs - Integrated Filing (Financial)
-
Aarti Pharmalabs - Integrated Filing- Financial
-
Aarti Pharmalabs Q3 net profit jumps 52.56% at Rs 73.52 cr
-
Aarti Pharmalabs - Financial Results For Quarter Ended December 31, 2024
-
Aarti Pharmalabs - Financial Result Updates
-
Aarti Pharmalabs - Board Meeting Outcome for Financial Results For Quarter Ended December 31, 2024
-
Aarti Pharmalabs - Dividend
-
Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aarti Pharmalabs - Board Meeting Intimation
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Aarti Pharmalabs - Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Nine-Months Ende
-
Aarti Pharmalabs - Action(s) taken or orders passed
-
Aarti Pharmalabs - Re-Opening Of Manufacturing Activities At The Company'S Vapi Plant
-
Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Acquisition
-
Aarti Pharmalabs - Acquisition
-
Aarti Pharmalabs - Closure Of Manufacturing Activities At The\r\nCompany'S Vapi Plant
-
Aarti Pharmalabs - Action(s) taken or orders passed
-
Aarti Pharmalabs - Trading Window-XBRL
-
Aarti Pharmalabs - Trading Window
-
Aarti Pharmalabs - Agreements,Contracts,Arrangements,MOU-XBRL
-
Aarti Pharmalabs - Agreements
-
Aarti Pharmalabs - Disclosure under Regulation 30A of LODR
Key fundamentals
Evaluate the intrinsic value of Aarti Pharmalabs Ltd stock
| Name | March-24 | March-23 | March-22 | ||
|---|---|---|---|---|---|
| Assets | 1872.2571 | 1645.2909 | 1608.9004 | ||
| Liabilities | 1872.2571 | 1645.2909 | 1608.9004 | ||
| Equity | 45.313 | 45.313 | 45.563 | ||
| Gross Profit | 346.1585 | 308.3352 | 179.7858 | ||
| Net Profit | 200.6454 | 171.7268 | 106.7261 | ||
| Cash From Operating Activities | 183.6944 | 228.6894 | -64.8426 | ||
| NPM(%) | 13.35 | 11.36 | 11.34 | ||
| Revenue | 1502.1319 | 1511.2478 | 941.021 | ||
| Expenses | 1155.9734 | 1202.9126 | 761.2352 | ||
| ROE(%) | 10.8 | 9.24 | 5.74 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 14 Feb 2025 | 2.5 | 50 | 0 | 636.3 |
| 31 Jul 2024 | 1 | 20 | 0 | 520.05 |
| 2 | 40 | 0 | 557.85 |
Peers
Other companies within the same industry or sector that are comparable to Aarti Pharmalabs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Sharda Cropchem Ltd | 546.30 | 0.44 | 20.18 | 6674.51 | 35.34 | 0.55 |
| Amines and Plasticizers Ltd | 207.56 | -3.66 | 27.75 | 4070.38 | 361.94 | 0.24 |
| Grauer and Weil (India) Ltd | 115.60 | 0.00 | 32.66 | 16771.71 | 322.62 | 0.43 |
| HP Adhesives Ltd | 45.32 | -3.04 | 21.28 | 6796.88 | 111.94 | 0.00 |
Company Info
Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company 2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.
Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company 2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.
Read More
Parent Organisation
Aarti Pharmalabs Ltd.
Founded
22/11/2019
Managing Director
Mr.Narendra J Salvi
NSE Symbol
AARTIPHARMEQ
FAQ
The current price of Aarti Pharmalabs Ltd is ₹ 738.95.
The 52-week high for Aarti Pharmalabs Ltd is ₹ 748.50 and the 52-week low is ₹ 726.60.
The market capitalization of Aarti Pharmalabs Ltd is currently ₹ 6696.81. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Aarti Pharmalabs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Aarti Pharmalabs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarti Pharmalabs Ltd shares.
The CEO of Aarti Pharmalabs Ltd is Mr.Narendra J Salvi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
